The Role of Cisplatin Prodrugs Bonded to Polymer Carriers for Nanodrug-targeted Treatment of In situ Hepatocellular Carcinoma
Although the inhibitory effect of M(P3) on HCC is not as good as cisplatin, M(P3) has significantly lower hepatorenal toxicity and remarkably higher cell Pt contents.
Authors
- Jie Hou (ORCID: https://orcid.org/0000-0002-1870-8694)
- Lan Luo (ORCID: https://orcid.org/0000-0001-7592-2913)
- Zhan Wang (ORCID: https://orcid.org/0000-0003-0852-4784)
- Zhijian Li (ORCID: https://orcid.org/0000-0002-1523-1333)
Institutions
- Shenzhen Bao'an District People's Hospital (CN)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-05-30
- DOI
- https://doi.org/10.2174/0118715206347681250312142125
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00